Oral Answers to Questions

Chi Onwurah Excerpts

Wednesday 8th January 2025 Commons Chamber

[Mr Speaker]

I call the Chair of the Science, Innovation and Technology Committee.

[Chi Onwurah (Newcastle upon Tyne Central and West) (Lab)]

Last month, the Select Committee brought festive cheer by hearing how British science is advancing the eradication of diseases such as cervical cancer, HIV/AIDS and malaria, through innovative and exciting new treatments and diagnostics. We also heard about the challenges of driving innovation through the NHS. Newcastle company AMLo Biosciences said that adoption is much quicker in the US, and others criticised bureaucratic procurement processes and a culture of inertia. Successive Governments have struggled with this challenge, so what specific steps is the Secretary of State taking with the Health Secretary to ensure that British patients benefit from innovation?

[Peter Kyle]

I am grateful for that question and for the work that my hon. Friend’s Committee is doing to highlight the incredibly important challenge that we face as a Government and a country. For the first time, the Health Secretary has adopted the spreading of innovation through the NHS as a personal mission as part of the role of the Secretary of State, and we co-chair the Office for Life Sciences. Together, our two Departments are not only seeking to harness the power of technology, but working together, under the leadership of the Health Secretary, to drive that innovation. Such innovation cannot be locked up in one innovative health trust; it must be put to use across the NHS for every patient from every part of the United Kingdom.